InvestorsHub Logo
Followers 0
Posts 69
Boards Moderated 0
Alias Born 02/14/2021

Re: iwasadiver post# 355218

Monday, 02/15/2021 7:18:59 PM

Monday, February 15, 2021 7:18:59 PM

Post# of 703849

I believe that’s the only real option.



Yeah, I don't see it that way at all. In fact, taking the "wait for publication" route that you and so many here think they are doing would be highly unusual. It's not the way it is usually done, and that in itself is a major strike against its probability. No matter how much one believes they are "waiting on publication", you are kidding yourself or disingenuous if you deny this simple truth.

Deviating from the normal course of announcing TLD and seeking approval would be taking a risk, and it would seem an unnecessary risk if the data were good. You can always release TLD and then go for the publication later, so why haven't they done that? Taking such an unorthodox risk would not seem advisable or likely, unless . . .

The results are bad. If the results are bad, then I could see waiting on a publication in order to add as much context to the bad data as possible, and then hope for the best. Now, I would buy that as a likely explanation, and it would also explain why they aren't saying anything to shareholders.

If the data were really good, though, there's just no way they would be sitting on it for months now. Nothing anyone can say will convince me otherwise because that would be a unicorn, and I don't believe in unicorns.

Hope I am wrong, but your explanation seems to be fitting a lot of square pegs into round holes in order to reach the desired conclusion. When you step back and look at things rationally from a wider perspective, waiting for months on a publication when you are holding great biomedical news that will immediately save lives makes neither logical nor common sense, and, frankly, it just isn't done that way.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News